| Trial ID: | L4514 |
| Source ID: | NCT05579119
|
| Associated Drug: |
Sitagliptin 100mg
|
| Title: |
SITAgliptin Plus GLARgine to Glycemic Control in the Hospital Setting (SITAGLAR-H)
|
| Acronym: |
SITAGLAR-H
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Type 2 Diabetes
|
| Interventions: |
DRUG: Sitagliptin 100mg|DRUG: Glargine|DRUG: Lispro
|
| Outcome Measures: |
Primary: Change of the mean daily blood glucose levels during hospital, Change of the mean daily blood glucose during the hospitalization between the groups, During hospitalization | Secondary: Percentage of blood glucose readings in 100-180 mg/dL range, Percentage of BG readings in the desired range of 100-180 mg/dl out of all avaialble BG readings., During hospitalization, up to 10 days|Dose of Insulin, Average daily amount of insulin used., During hospitalization, up to 10 days|Incidence of hypoglycemia (BG <70 mg/dL), Number of BG readings \<70 mg/dL in each group., During hospitalization, up to 10 days|Percentage of blood glucose reading >180 mg/dL, Percentage of BG reading \>180 mg/dL, During hospitalization, up to 10 days|Mean length of stay in days in the hospital among different groups, The duration of stay in days in the hospital between the two groups is calculated and mean number of days is measured., During hospitalization, up to 10 days
|
| Sponsor/Collaborators: |
Sponsor: Hospital de Especialidades, Centro Medico Nacional "La Raza", Instituto Mexicano del Seguro Social | Collaborators: National Polytechnic Institute, Mexico
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE4
|
| Enrollment: |
76
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
|
| Start Date: |
2022-07-06
|
| Completion Date: |
2023-08-24
|
| Results First Posted: |
|
| Last Update Posted: |
2023-09-26
|
| Locations: |
División de Investigación en Salud, Hospital de Especialidades, Centro Médico Nacional "La Raza", IMSS, Mexico City, 02990, Mexico
|
| URL: |
https://clinicaltrials.gov/show/NCT05579119
|
